Clinical Trials Directory

Trials / Completed

CompletedNCT05261763

Effects of Trigger Point Dry Needling in Individuals With Patello Femoral Pain Syndrome : A Randomized Controlled Trial

Study on the Effects of Trigger Point Dry Needling on Patients With Patello-femoral Pain Syndrome: A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
Riphah International University · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

A double blinded clinical controlled trial will be performed on individuals with patello femoral pain syndrome in which Trigger Point Dry Needling will be given to experimental group while Sham Needling will be given to the control group, targeting the trigger points present in the Quadriceps of affected individuals assessing the pain,functional disability and range of motion of the affected individuals.

Detailed description

A double blinded Randomized Controlled Trial of 6 months study after the approval of synopsis, will be conducted. Convenience sampling technique will be used to enroll the patients. Patients will be selected according to predefined inclusion and exclusion criteria. All patients who fulfill inclusion criteria will be allocated in two group through randomization by lottery method. Group A will receive TrP-DN and group B will receive Sham Needling. Both groups will be asked to perform stretching exercise of Quadriceps daily after needling. The patients' outcomes will be measured by VAS for pain intensity and Kujala Questionnaire for functional status. The comparison between pre-treatment and post-treatment data will be done after 3 months. Informed consents will be taken from each patient. Data entry and analysis will be done with SPSS 23.

Conditions

Interventions

TypeNameDescription
OTHERDry Needlingabc
OTHERSham Dry Needingxyz

Timeline

Start date
2021-03-15
Primary completion
2022-03-01
Completion
2022-03-01
First posted
2022-03-02
Last updated
2022-04-22

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT05261763. Inclusion in this directory is not an endorsement.